10-117134371-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001112704.2(VAX1):​c.642G>A​(p.Leu214Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,211,662 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0010 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

VAX1
NM_001112704.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -3.17

Publications

0 publications found
Variant links:
Genes affected
VAX1 (HGNC:12660): (ventral anterior homeobox 1) This gene encodes a homeo-domain containing protein from a class of homeobox transcription factors which are conserved in vertebrates. Genes of this family are involved in the regulation of body development and morphogenesis. The most conserved genes, called HOX genes are found in special gene clusters. This gene belongs to the VAX subfamily and lies in the vicinity of the EMX homeobox gene family. Another member of VAX family is located on chromosome 2. The encoded protein may play an important role in the development of anterior ventral forebrain and visual system. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
VAX1 Gene-Disease associations (from GenCC):
  • microphthalmia, syndromic 11
    Inheritance: AR Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 10-117134371-C-T is Benign according to our data. Variant chr10-117134371-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 283191.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VAX1NM_001112704.2 linkc.642G>A p.Leu214Leu synonymous_variant Exon 3 of 3 ENST00000369206.6 NP_001106175.1 Q5SQQ9-1
VAX1NM_199131.3 linkc.430-1894G>A intron_variant Intron 2 of 3 NP_954582.1 Q5SQQ9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VAX1ENST00000369206.6 linkc.642G>A p.Leu214Leu synonymous_variant Exon 3 of 3 5 NM_001112704.2 ENSP00000358207.4 Q5SQQ9-1
VAX1ENST00000277905.6 linkc.430-1894G>A intron_variant Intron 2 of 3 1 ENSP00000277905.2 Q5SQQ9-2

Frequencies

GnomAD3 genomes
AF:
0.00104
AC:
154
AN:
148374
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000439
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00429
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00296
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000793
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000969
AC:
3
AN:
3096
AF XY:
0.000475
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00413
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000585
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00115
AC:
1226
AN:
1063180
Hom.:
2
Cov.:
32
AF XY:
0.00111
AC XY:
558
AN XY:
504508
show subpopulations
African (AFR)
AF:
0.000185
AC:
4
AN:
21674
American (AMR)
AF:
0.00366
AC:
27
AN:
7372
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12892
East Asian (EAS)
AF:
0.00223
AC:
53
AN:
23784
South Asian (SAS)
AF:
0.000543
AC:
13
AN:
23962
European-Finnish (FIN)
AF:
0.0000963
AC:
2
AN:
20770
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2756
European-Non Finnish (NFE)
AF:
0.00116
AC:
1057
AN:
908340
Other (OTH)
AF:
0.00168
AC:
70
AN:
41630
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
72
144
217
289
361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
153
AN:
148482
Hom.:
2
Cov.:
32
AF XY:
0.000995
AC XY:
72
AN XY:
72396
show subpopulations
African (AFR)
AF:
0.000438
AC:
18
AN:
41124
American (AMR)
AF:
0.00422
AC:
63
AN:
14942
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3424
East Asian (EAS)
AF:
0.00297
AC:
15
AN:
5044
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9062
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.000793
AC:
53
AN:
66804
Other (OTH)
AF:
0.00
AC:
0
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000900
Hom.:
0
Bravo
AF:
0.00162

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Sep 22, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microphthalmia, syndromic 11 Benign:1
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

VAX1-related disorder Benign:1
Oct 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.1
DANN
Benign
0.90
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs554140675; hg19: chr10-118893882; API